WallStreetZenWallStreetZen

NASDAQ: APLS
Apellis Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for APLS

Based on 15 analysts offering 12 month price targets for Apellis Pharmaceuticals Inc.
Min Forecast
$46.00-21.74%
Avg Forecast
$76.67+30.43%
Max Forecast
$106.00+80.33%

Should I buy or sell APLS stock?

Based on 15 analysts offering ratings for Apellis Pharmaceuticals Inc.
Buy
Strong Buy
7 analysts 46.67%
Buy
4 analysts 26.67%
Hold
4 analysts 26.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APLS stock forecasts and price targets.

APLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2024-03-04Find Out Why
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-28
Baird
Top 38%
63
BuyReiterates$81.00+37.80%2024-02-06
Jefferies
Top 17%
84
Strong BuyUpgrades$80.00+36.10%2024-02-05Find out why
Oppenheimer
Top 21%
80
BuyMaintains$79.00+34.40%2024-01-30
Needham
Top 3%
98
BuyMaintains$75.00+27.59%2024-01-24
Raymond James
Top 9%
92
Strong BuyMaintains$106.00+80.33%2024-01-11

1 of 2

Forecast return on equity

Is APLS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is APLS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

APLS revenue forecast

What is APLS's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$785.7M+98.1%
Avg 2 year Forecast
$1.2B+194.56%
Avg 3 year Forecast
$1.6B+296.41%
APLS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

APLS revenue growth forecast

How is APLS forecast to perform vs Biotechnology companies and vs the US market?
Company
58.26%
Industry
39.22%
Market
10.52%
APLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APLS$58.78$76.67+30.43%Buy
EXEL$23.73$27.57+16.19%Strong Buy
CYTK$70.11$84.39+20.36%Strong Buy
PCVX$68.31$96.00+40.54%Strong Buy
JAZZ$120.42$193.09+60.35%Strong Buy

Apellis Pharmaceuticals Stock Forecast FAQ

Is Apellis Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NASDAQ: APLS) stock is to Buy APLS stock.

Out of 15 analysts, 7 (46.67%) are recommending APLS as a Strong Buy, 4 (26.67%) are recommending APLS as a Buy, 4 (26.67%) are recommending APLS as a Hold, 0 (0%) are recommending APLS as a Sell, and 0 (0%) are recommending APLS as a Strong Sell.

If you're new to stock investing, here's how to buy Apellis Pharmaceuticals stock.

What is APLS's revenue growth forecast for 2024-2026?

(NASDAQ: APLS) Apellis Pharmaceuticals's forecast annual revenue growth rate of 58.26% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Apellis Pharmaceuticals's revenue in 2024 is $396,591,000.On average, 8 Wall Street analysts forecast APLS's revenue for 2024 to be $94,735,654,011, with the lowest APLS revenue forecast at $85,969,963,767, and the highest APLS revenue forecast at $110,908,681,095. On average, 8 Wall Street analysts forecast APLS's revenue for 2025 to be $140,862,996,273, with the lowest APLS revenue forecast at $125,872,876,146, and the highest APLS revenue forecast at $151,624,314,463.

In 2026, APLS is forecast to generate $189,571,390,873 in revenue, with the lowest revenue forecast at $171,666,206,964 and the highest revenue forecast at $217,408,893,447.

What is APLS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: APLS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is APLS's Price Target?

According to 15 Wall Street analysts that have issued a 1 year APLS price target, the average APLS price target is $76.67, with the highest APLS stock price forecast at $106.00 and the lowest APLS stock price forecast at $46.00.

On average, Wall Street analysts predict that Apellis Pharmaceuticals's share price could reach $76.67 by Mar 27, 2025. The average Apellis Pharmaceuticals stock price prediction forecasts a potential upside of 30.43% from the current APLS share price of $58.78.

What is APLS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: APLS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.